Screener
Ocular Therapeutix OCUL Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Accrued expenses | (8,441) | (5,145) |
| Deferred revenue | — | (64) |
| Operating lease liabilities | 1,768 | (256) |
| Net cash used in operating activities | (65,993) | (44,671) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (4,662) | (1,933) |
| Net cash used in investing activities | (4,662) | (1,933) |
| Cash flows from financing activities: |
Item 1. Financial Statements (unaudited)
FAQ
- What is Ocular Therapeutix's operating cash flow?
- Ocular Therapeutix (OCUL) reported operating cash flow of -$65.99M in Q1 2026.
- How has Ocular Therapeutix's operating cash flow changed year-over-year?
- Ocular Therapeutix's operating cash flow decreased by 47.7% year-over-year, from -$44.67M to -$65.99M.
- What is the long-term trend for Ocular Therapeutix's operating cash flow?
- Over 4 years (2021 to 2025), Ocular Therapeutix's operating cash flow has grown at a 33.0% compound annual growth rate (CAGR), from -$65.55M to -$204.88M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Ocular Therapeutix's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude